Today's Top 20 StoriesRSS
Johnson & Johnson is a giant in the healthcare space, and investing in the company's stock could be a good move, according to an Investor Place report. By Laura Dyrda -
With diabetes becoming more common, and one of the most frequent comorbidities in patients with cervical spondylotic myelopathy, a group of researchers sought to find risk factors for poor outcomes in this patient population and published their findings in The Journal of Bone & Joint Surgery. By Laura Dyrda -
The Food and Drug Administration published draft guidance for the minimal manipulation of human cells tissues and cellular and tissue-based products, and now device companies are making comments.  By Laura Dyrda -

Becker's hosts 13th annual spine conference 

Becker's Healthcare will host its 13th annual spine, orthopedic and pain management-driven ASC conference and the business of spine in Chicago June 11-13, 2015. Come here more than 100 surgeons and healthcare leaders speak at this event, focused on orthopedics, spine and pain!  
Around 20 years ago, Medicrea launched as an orthopedic device company. In 2006, the company went public and began investing in research and development focusing on new technologies to improve standard spinal products. By Laura Dyrda -
Here are updates from the past week on five orthopedic and spine device company stock reports. By Laura Dyrda -
The use of composites in the global orthopedic industry is expected to grow at an average rate of 8.1 percent to reach $596 million by 2020, according to a market report published by ABMRG.  By Anuja Vaidya -
Zimmer appointed Michael J. Farrell to its board of directors.  By Anuja Vaidya -
Surgical site infections are serious complications and have a 6 percent to 24 percent prevalence rate among patients who undergo posterior spinal fusion for neuromuscular scoliosis, according to an article in The Journal of Bone & Joint Surgery. By Laura Dyrda -
The global trauma fixation market is expected to grow over the next four years, according to a MicroMarket Monitor report. By Laura Dyrda -
Two of the week's three worst medical device company stocks are from orthopedic companies — and the experts are advising to sell, according to an Investor Place report. By Laura Dyrda -
Medtronic, Zimmer or Stryker — who's stock is the best bet? By Laura Dyrda -
Leadership is always difficult when massive change occurs in any particular industry. Healthcare is no different. The current environment is wrought with change and especially difficult for independent physicians to navigate. By Laura Dyrda -
Zyga Technology raised $2 million in an equity-and-options round, hoping to eventually bring in $5 million, according to Mass Device report.  By Anuja Vaidya -
Plano-based Texas Institute of Spine and Neurosurgery announced that D Magazine has again named neurosurgeon Brent Morgan, MD, the best in Dallas for the ninth year running.  By Anuja Vaidya -
Is the freehand lateral mass screw fixation in the subaxial cervical spine safe? By Laura Dyrda -
A new study published in The Spine Journal examines whether cervical spine clearance protocols in California are effective at trauma centers. By Laura Dyrda -
Here are five key notes on spine and orthopedic device companies.  By Anuja Vaidya -
Oak Hill Hospital in Brooksville, Fla., added Juan Raposo, MD, to its physician team, according to a Tampa Bay Times report.  By Anuja Vaidya -
On Nov. 4, the Republican Party swept the midterm elections and gained control of Congress. The party now controls both the Congress and the Senate. Two spine surgeons discuss what this means for the industry.  By Anuja Vaidya -
Here are 10 spine surgeons and specialists who were in the news this past week. By Laura Dyrda -
Page 10 of 245